Taizhi Ao (太之奥)太之奥
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 大连天宇制药有限公司Chinese legal name: 大连天宇制药有限公司
主要成分Active Ingredients
- 金刚乙胺Jingang Yian
药物知识说明
金刚乙胺是一种在国家药监局注册认定的药品。该药品含有金刚乙胺-4db97d09等成分。
该药品关联的活性成分包括：金刚乙胺Jingang Yian。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：大连天宇制药有限公司Chinese legal name: 大连天宇制药有限公司。
您可以探索含有相同成分的其他药品：金刚乙胺-4db97d09成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 太之奥) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 金刚乙胺Jingang Yian.
Manufacturers recorded for this product: 大连天宇制药有限公司Chinese legal name: 大连天宇制药有限公司.
Explore other medicines containing the same ingredient: 金刚乙胺 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 太之奥Recorded Chinese name: 太之奥
- 剂型Dosage form: 颗粒剂Granules
- 规格Specification: 2g*50mg*12袋2g*50 mg × 12 sachets
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 大连天宇制药有限公司Chinese legal name: 大连天宇制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20051475
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20051475
Manufacturer
Chinese legal name: 大连天宇制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
2g*50 mg × 12 sachets
中文说明书原文Original Chinese source label
批准文号
国药准字H20051475
生产企业
大连天宇制药有限公司(国产)
适应症
本品用于成人预防和治疗A型流感病毒感染，也适用于儿童预防A型流感病毒感染。
用法用量
口服。撕开小袋，把药物倒入适量的温水中，摇匀，即可服用。1. 成人和儿童的预防用药：成人：成人的推荐剂量是每次100mg(2包)，每日二次。儿童：10岁以下儿童，每日一次，每次5mg/kg，每日剂量不超过150mg。10岁或以上的儿童，用量与成年人一致。2. 成人的治疗用药：成人的推荐剂量为每次100mg(2包)，每日二次。在出现A型流行性感冒的症状和体征时，服用本品越早越好，在48小时内服用本品治疗效果更好，从症状开始连续治疗约七天。
不良反应
据资料介绍，在临床对照试验中，对1,027名患者在推荐的每日0.2g剂量下服用本品，多数的不良事件为消化系统和神经系统反应。
禁忌
对金刚烷系列药物（包括金刚烷胺和金刚乙胺等）过敏的患者禁用。
注意事项
据报道，有癫痫病史的患者服用盐酸金刚烷胺后，癫痫发作的发病率增加了。
贮藏
避光
规格
2g*50mg*12袋
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.